From Ambiguity To Action: The FDA’s New Nitrosamine Guidance
In this webinar, Adare’s Jason Brown breaks down the FDA’s newly finalized guidance, providing a clear overview and exploring both proven and innovative techniques to minimize nitrosamine formation in your products while ensuring compliance.
.png?width=363&height=236&name=Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).png)
